Search Results - "Kleinman, JE"

Refine Results
  1. 1

    Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia by Vawter, Marquis P, Shannon Weickert, Cynthia, Ferran, Erick, Matsumoto, Mitsuyuki, Overman, Kevin, Hyde, Thomas M, Weinberger, Daniel R, Bunney, William E, Kleinman, Joel E

    Published in Neurochemical research (01-06-2004)
    “…Microarray expression studies have reported decreased mRNA expression of histidine triad nucleotide-binding protein (HINT1) and cytosolic malate dehydrogenase…”
    Get full text
    Journal Article
  2. 2
  3. 3

    RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder by Akula, N, Barb, J, Jiang, X, Wendland, J R, Choi, K H, Sen, S K, Hou, L, Chen, D T W, Laje, G, Johnson, K, Lipska, B K, Kleinman, J E, Corrada-Bravo, H, Detera-Wadleigh, S, Munson, P J, McMahon, F J

    Published in Molecular psychiatry (01-11-2014)
    “…RNA-sequencing (RNA-seq) is a powerful technique to investigate the complexity of gene expression in the human brain. We used RNA-seq to survey the brain…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Critical Factors in Gene Expression in Postmortem Human Brain: Focus on Studies in Schizophrenia by Lipska, Barbara K., Deep-Soboslay, Amy, Weickert, Cynthia Shannon, Hyde, Thomas M., Martin, Catherine E., Herman, Mary M., Kleinman, Joel E.

    Published in Biological psychiatry (1969) (15-09-2006)
    “…Studies of postmortem human brain are important for investigating underlying pathogenic molecular mechanisms of neuropsychiatric disorders. They are, however,…”
    Get full text
    Journal Article
  6. 6

    Allelic variation in GAD1 (GAD ) is associated with schizophrenia and influences cortical function and gene expression by STRAUB, R. E, LIPSKA, B. K, EGAN, M. F, GOLDBERG, T. E, CALLICOTT, J. H, MAYHEW, M. B, VAKKALANKA, R. K, KOLACHANA, B. S, KLEINMAN, J. E, WEINBERGER, D. R

    Published in Molecular psychiatry (01-09-2007)
    “…Cortical GABAergic dysfunction has been implicated as a key component of the pathophysiology of schizophrenia and decreased expression of the…”
    Get full text
    Journal Article
  7. 7

    Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia by WEICKERT, C. S, HYDE, T. M, LIPSKA, B. K, HERMAN, M. M, WEINBERGER, D. R, KLEINMAN, J. E

    Published in Molecular psychiatry (01-06-2003)
    “…Anatomical and molecular abnormalities of excitatory neurons in the dorsolateral prefrontal cortex (DLPFC) are found in schizophrenia. We hypothesized that…”
    Get full text
    Journal Article
  8. 8

    Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia by Wong, J, Hyde, T.M, Cassano, H.L, Deep-Soboslay, A, Kleinman, J.E, Weickert, C. Shannon

    Published in Neuroscience (01-09-2010)
    “…Abstract The brain-derived neurotrophic factor (BDNF) gene contains multiple 5′ promoters which generate alternate transcripts. Previously, we found that…”
    Get full text
    Journal Article
  9. 9

    Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness by Perlman, William R., Webster, Maree J., Kleinman, Joel E., Weickert, Cynthia Shannon

    Published in Biological psychiatry (1969) (01-12-2004)
    “…The amygdala is a limbic structure involved in the stress response and the regulation of emotional behaviors, both of which are disrupted in patients with…”
    Get full text
    Journal Article
  10. 10

    Catechol-O-Methyltransferase Genotype and Dopamine Regulation in the Human Brain by Akil, Mayada, Kolachana, Bhaskar S, Rothmond, Debora A, Hyde, Thomas M, Weinberger, Daniel R, Kleinman, Joel E

    Published in The Journal of neuroscience (15-03-2003)
    “…A functional polymorphism in the gene for catechol-O-methyltransferase (COMT) has been shown to affect executive cognition and the physiology of the prefrontal…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Catechol-o-Methyltransferase Enzyme Activity and Protein Expression in Human Prefrontal Cortex across the Postnatal Lifespan by Tunbridge, EM, Weickert, CS, Kleinman, JE, Herman, MM, Chen, J, Kolachana, BS, Harrison, PJ, Weinberger, DR

    Published in Cerebral cortex (New York, N.Y. 1991) (01-05-2007)
    “…The prefrontal cortex (PFC) dopamine system, which is critical for modulating PFC function, undergoes remodeling until at least young adulthood in primates…”
    Get full text
    Journal Article
  13. 13

    Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia by Webster, M.J., O’Grady, J., Kleinman, J.E., Weickert, C.S.

    Published in Neuroscience (2005)
    “…Recent studies have shown a decrease in glial number and glial fibrillary acidic protein (GFAP) levels in the frontal and cingulate cortices of individuals…”
    Get full text
    Journal Article
  14. 14

    Real-time remote monitoring of water quality: a review of current applications, and advancements in sensor, telemetry, and computing technologies by Glasgow, Howard B, Burkholder, JoAnn M, Reed, Robert E, Lewitus, Alan J, Kleinman, Joseph E

    “…Recent advances in communication and sensor technology have catalyzed progress in remote monitoring capabilities for water quality. As a result, the ability to…”
    Get full text
    Journal Article
  15. 15

    Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia by HASHIMOTO, R, STRAUB, R. E, WEICKERT, C. S, HYDE, T. M, KLEINMAN, J. E, WEINBERGER, D. R

    Published in Molecular psychiatry (01-03-2004)
    “…Genetic linkage and association have implicated neuregulin-1 (NRG-1) as a schizophrenia susceptibility gene. We measured mRNA expression levels of the three…”
    Get full text
    Journal Article
  16. 16

    Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype by Conejero-Goldberg, C, Hyde, T M, Chen, S, Dreses-Werringloer, U, Herman, M M, Kleinman, J E, Davies, P, Goldberg, T E

    Published in Molecular psychiatry (01-08-2011)
    “…Alzheimer's disease (AD) is a neurodegenerative condition characterized histopathologically by neuritic plaques and neurofibrillary tangles. The objective of…”
    Get full text
    Journal Article
  17. 17

    Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function by Matsumoto, M., Weickert, C.Shannon, Akil, M., Lipska, B.K., Hyde, T.M., Herman, M.M., Kleinman, J.E., Weinberger, D.R.

    Published in Neuroscience (01-01-2003)
    “…Catechol O-methyltransferase (COMT) is involved in the inactivation of catecholamines, including the neurotransmitter dopamine. A Val 108/158 Met functional…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects by WOLF, S. S, HYDE, T. M, SAUNDERS, R. C, HERMAN, M. M, WEINBERGER, D. R, KLEINMAN, J. E

    Published in Journal of Neural Transmission (01-01-1995)
    “…Neurotensin, an endogenous peptide and putative neurotransmitter, exhibits a wide range of interactions with dopaminergic neurons and displays some actions…”
    Get full text
    Journal Article
  20. 20

    BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan by Webster, M.J., Herman, M.M., Kleinman, J.E., Shannon Weickert, C.

    Published in Gene Expression Patterns (01-10-2006)
    “…Brain-derived neurotrophic factor (BDNF) and its receptor tyrosine kinase B (trkB) influence neuronal survival, differentiation, synaptogenesis, and…”
    Get full text
    Journal Article